Profile data is unavailable for this security.
About the company
Aurora Spine Corporation is a Canada-based company focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies. The Company’s products generally fall into three product lines: interspinous process (ISP) lumbar fusion devices, Stand-alone (SA) Cervical and Lumbar fusion cages, and SI joint fusion devices. Its ISP lumbar fusion devices include the ZIP, the ZIP ULTR, the ZIP LP and the ZIP-51. It also offers a line of interbody products: Discovery for cervical procedures; SOLO, an ALIF 3D-printed stand-alone lumbar fusion device; SiLO, a posterior allograft implant; and SiLO TFX, a titanium implant device, both for sacroiliac (SI) joint fusion, and Dexa-C a 3D printed cervical fusion device which is paired with the Apollo cervical plate. In addition, the Company markets certain third-party-developed products used during spine surgeries (i.e. surgical screws and bone growth biologic materials).
- Revenue in CAD (TTM)24.46m
- Net income in CAD-1.82m
- Incorporated2013
- Employees13.00
- LocationAurora Spine Corp20 HOLLY STREET, SUITE 300TORONTO M4S 3B1CanadaCAN
- Phone+1 (760) 424-2004
- Websitehttps://www.aurora-spine.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NuGen Medical Devices Inc | 589.43k | -2.12m | 6.75m | 12.00 | -- | -- | -- | 11.45 | -0.0092 | -0.0092 | 0.0026 | -0.0381 | 0.0461 | 0.7839 | 19.59 | -- | -16.58 | -- | -20.05 | -- | 54.97 | -- | -359.36 | -- | 3.90 | -- | 1.90 | -- | 204.73 | -- | 44.18 | -- | -- | -- |
| VVT Med Inc | 9.49k | -3.17m | 17.91m | 10.00 | -- | -- | -- | 1,887.36 | -0.1048 | -0.1048 | 0.0005 | -0.0117 | 0.0072 | -- | -- | -- | -241.79 | 437.87 | -- | -- | 71.43 | -- | -33,401.51 | 1,850.65 | 0.6354 | -19.39 | 2.53 | 0.00 | -- | -- | 15.43 | -- | -- | -- |
| Medx Health Corp | 522.91k | -5.30m | 19.50m | -- | -- | -- | -- | 37.28 | -0.0187 | -0.0187 | 0.0018 | -0.0332 | 0.4908 | 0.8651 | 13.37 | -- | -497.63 | -619.54 | -- | -- | 33.60 | 45.55 | -1,013.97 | -858.59 | 0.0567 | -1.70 | -- | -- | 7.37 | -10.66 | 20.25 | -- | -- | -- |
| Nanalysis Scientific Corp | 41.74m | -12.38m | 21.46m | 130.00 | -- | 1.58 | -- | 0.5141 | -0.1092 | -0.1092 | 0.3672 | 0.098 | 0.9633 | 6.85 | 5.00 | -- | -28.57 | -21.20 | -44.19 | -30.04 | 26.96 | 35.26 | -29.66 | -37.30 | 0.6242 | -2.41 | 0.6248 | -- | 59.82 | 40.32 | 15.95 | -- | -9.96 | -- |
| VentriPoint Diagnostics Ltd | 175.62k | -4.06m | 22.16m | -- | -- | -- | -- | 126.18 | -0.0248 | -0.0248 | 0.0011 | -0.0278 | 0.3207 | -- | 1.04 | -- | -741.44 | -109.11 | -- | -191.33 | 0.00 | 86.67 | -2,311.87 | -8,206.33 | -- | -8.35 | -- | -- | 93.51 | 3.27 | -0.9776 | -- | -- | -- |
| Aurora Spine Corp | 24.46m | -1.82m | 23.17m | 13.00 | -- | 4.51 | -- | 0.947 | -0.0233 | -0.0233 | 0.314 | 0.0665 | 1.52 | 1.93 | 5.51 | -- | -11.30 | -13.83 | -17.27 | -19.19 | 59.74 | 52.84 | -7.44 | -10.24 | 1.10 | -5.45 | 0.4836 | -- | 20.95 | 9.51 | 40.34 | -- | 17.34 | -- |
| Cheelcare Inc | 809.92k | -2.24m | 33.07m | -- | -- | 43.30 | -- | 40.83 | -0.2197 | -0.2197 | 0.0964 | 0.0393 | 0.679 | -- | 3.61 | -- | -188.00 | -- | -335.28 | -- | 54.44 | -- | -276.88 | -- | 1.29 | -3.98 | 0.3945 | -- | -- | -- | -50.62 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Ogorek Wealth Management LLCas of 31 Dec 2025 | 3.00k | 0.00% |
